1
Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC)
Condition(s): Breast Cancer Last Updated: June 22, 2012Withdrawn
Hide Studies Not Seeking New Volunteers
Condition(s): Breast Cancer Last Updated: June 22, 2012Withdrawn
Condition(s): Advanced Solid Tumors Last Updated: November 7, 2011Recruiting
Condition(s): Non-small Cell Lung Cancer Last Updated: November 7, 2011Terminated